文献速递骨质疏松与代谢性骨病

改善抗骨质疏松药物依从性的干预措施:一项更新的系统综述

Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review.
PubMed 文献 · Osteoporos Int · 2020-05-01

该更新系统综述检索2012年7月至2018年12月发表的原始研究,评估患者教育、用药方案、监测监督及跨学科协作等干预对抗骨质疏松药物依从性和持续性的效果。共纳入15项研究(12项为随机对照试验),发现多组分且患者主动参与的干预最为有效,结果提示需基于医患协作的个体化方案改善依从性。

要点

  • 多组分且患者主动参与的干预对提高抗骨质疏松药物依从性和持续性最有效。
  • 患者教育、监测监督、用药方案调整及跨学科协作的干预效果结果不一。
  • 与既往综述相比,干预转向更多患者参与、咨询和共享决策。

核心结论

  • 患者教育、监测监督、用药方案改变和跨学科协作对抗骨质疏松药物依从性和持续性的效果结果不一,多组分且患者主动参与的干预效果更积极。

研究设计与样本

  • 在Medline(PubMed)、Embase(Ovid)、Cochrane Library、Current Controlled Trials、ClinicalTrials.gov、NHS Centre for Review and Dissemination、CINHAL和PsycINFO中检索2012年7月至2018年12月发表的评估改善抗骨质疏松药物依从性和持续性干预的原始研究,并评估纳入研究质量。

主要发现

  • 初检585项研究中15项符合纳入标准,其中12项为随机对照试验。
  • 干预分为患者教育(n=9)、用药方案(n=3)、监测与监督(n=2)和跨学科协作(n=1)四类。
  • 在大多数干预亚型中,对依从性和持续性的结果不一。
  • 基于患者教育和咨询的多组分干预在提高依从性和/或持续性方面最为有效。

临床怎么用

  • 优先采用多组分且患者主动参与的干预策略以提高抗骨质疏松药物依从性和持续性。
  • 根据患者与医疗提供者协作制定个体化方案,并融入咨询和共享决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: An earlier systematic review on interventions to improve adherence and persistence was updated. Fifteen studies investigating the effectiveness of patient education, drug regimen, monitoring and supervision, and interdisciplinary collaboration as a single or multi-component intervention were appraised. Multicomponent interventions with active patient involvement were more effective. INTRODUCTION: This study was conducted to update a systematic literature review on interventions to improve adherence to anti-osteoporosis medications. METHODS: A systematic literature review was carried out in Medline (using PubMed), Embase (using Ovid), Cochrane Library, Current Controlled Trials, ClinicalTrials.gov , NHS Centre for Review and Dissemination, CINHAL, and PsycINFO to search for original studies that assessed interventions to improve adherence (comprising initiation, implementation, and discontinuation) and persistence to anti-osteoporosis medications among patients with osteoporosis, published between July 2012 and December 2018. Quality of included studies was assessed. RESULTS: Of 585 studies initially identified, 15 studies fulfilled the inclusion criteria of which 12 were randomized controlled trials. Interventions were classified as (1) patient education (n = 9), (2) drug regimen (n = 3), (3) monitoring and supervision (n = 2), and (4) interdisciplinary collaboration (n = 1). In most subtypes of interventions, mixed results on adherence (and persistence) were found. Multicomponent interventions based on patient education and counseling were the most effective interventions when aiming to increase adherence and/or persistence to osteoporosis medications. CONCLUSION: This updated review suggests that patient education, monitoring and supervision, change in drug regimen, and interdisciplinary collaboration have mixed results on medication adherence and persistence, with more positive effects for multicomponent interventions with active patient involvement. Compared with the previous review, a shift towards more patient involvement, counseling and shared decision-making, was seen, suggesting that individualized solutions, based on collaboration between the patient and the healthcare provider, are needed to improve adherence and persistence to osteoporosis medications.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Cornelissen D, de Kunder S, Si L, et al. Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int. 2020. PMID: 32358684. doi:10.1007/s00198-020-05378-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。